ClinicalTrials.Veeva

Menu

Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component

M

Medacta

Status

Completed

Conditions

Osteoarthritis, Hip

Treatments

Device: Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup.

Study type

Observational

Funder types

Industry

Identifiers

NCT03168750
MUSA-H-ML-001

Details and patient eligibility

About

This prospective study will evaluate the hip function and quality of life of patients operated for total hip arthroplasty with Masterloc femoral stem and MPACT acetabular cup. The results of this study will establish the performance of Masterloc femoral component (Medacta International SA) and MPACT acetabular component (Medacta International SA), and provide a general estimate of survivorship, clinical effectiveness and complications.

Enrollment

120 patients

Sex

All

Ages

Under 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Primary osteoarthritis of the hip necessitating primary hip replacement,
  • Suitability for straight cementless stem,
  • Adult male and female under 75 years old,
  • Ability to give informed consent ,
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up.

Exclusion criteria

  • Off-label use of the Medacta Masterloc femoral component and MPACT acetabular component
  • Post-traumatic deformity in the affected hip,
  • Patient suffering from Inflammatory arthritis including rheumatoid arthritis,
  • Patient suffering by congenital or developmental deformity,
  • Severe osteoporosis,
  • History of surgery in the affected hip,
  • Perioperative fracture,
  • Personality disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain,
  • Patients with a history of active infection
  • Pregnant women or those seeking to become pregnant

Trial design

120 participants in 1 patient group

Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup
Description:
All patients enrolled will receive the Medacta Masterloc Stem and MPACT cup with Highcross PE liner.
Treatment:
Device: Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup.

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems